Equity Overview
Price & Market Data
Price: $2.96
Daily Change: -$0.20 / 6.76%
Range: $2.95 - $3.14
Market Cap: $90,243,592
Volume: 67,451
Company Details
Employees: 92
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.